Our Expert in Cell Therapy Solutions

Paxton Provitera is an accomplished U.S. biomedical engineer with a PhD in Physiology and Biophysics. With a solid foundation in both biomedical engineering and advanced physiological sciences, he has made significant contributions to the field. As the R&D Project Manager at Pall Medical for 15 years, Paxton played a pivotal role in designing the selective filter for concentrating peripheral blood mononuclear cells. This innovation has been a key development in autologous cell therapy, particularly for the treatment of critical ischemia in lower limbs and diabetic foot ulcers.

Currently, Paxton serves as the leader of PAX Advanced Therapies, a company dedicated to the development of next-generation filtration and cell separation systems. His work focuses on tackling complex biomedical challenges and advancing cutting-edge methods that address the increasing demands of modern medicine and therapeutic interventions. Through his expertise and leadership, Paxton is contributing to the development of innovative technologies that have the potential to revolutionize treatments for a wide range of medical conditions.